1. The novel bronchodilator navafenterol: a phase 2a, multicentre, randomised, double-blind, placebo-controlled crossover trial in COPD. Issue 4 (7th April 2022) Authors: Singh, Dave; Beier, Jutta; Astbury, Carol; Belvisi, Maria G.; Da Silva, Carla A.; Jauhiainen, Alexandra; Jimenez, Eulalia; Lei, Alejhandra; Necander, Sofia; Smith, Jaclyn A.; Wählby Hamrén, Ulrika; Xin, Wenjing; Psallidas, Ioannis Journal: European respiratory journal Issue: Volume 59:Issue 4(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗